Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

2.

Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

3.

Global inequalities found in cancer research funding

4.

Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.

5.

Research has shown that Ga-68 FAPI PET enhances pancreatic cancer detection and staging.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot